4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Solution NMR assignment of the ARC4 domain of human tankyrase 2

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tankyrases are poly(ADP-ribose)polymerases (PARPs) which recognize their substrates via their ankyrin repeat cluster (ARC) domains. The human tankyrases (TNKS/TNKS2) contain five ARCs in their extensive N-terminal region; of these, four bind peptides present within tankyrase interactors and substrates. These short, linear segments, known as tankyrase-binding motifs (TBMs), contain some highly conserved features: an arginine at position 1, which occupies a predominantly acidic binding site, and a glycine at position 6 that is sandwiched between two aromatic side chains on the surface of the ARC domain. Tankyrases are involved in a multitude of biological functions, amongst them Wnt/β-catenin signaling, the maintenance of telomeres, glucose metabolism, spindle formation, the DNA damage response and Hippo signaling. As many of these are relevant to human disease, tankyrase is an important target candidate for drug development. With the emergence of non-catalytic (scaffolding) functions of tankyrase, it seems attractive to interfere with ARC function rather than the enzymatic activity of tankyrase. To study the mechanism of ARC-dependent recruitment of tankyrase binders and enable protein-observed NMR screening methods, we have as the first step obtained a full backbone and partial side chain assignment of TNKS2 ARC4. The assignment highlights some of the unusual structural features of the ARC domain.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.

          The stability of the Wnt pathway transcription factor beta-catenin is tightly regulated by the multi-subunit destruction complex. Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies. However, the development of targeted Wnt pathway inhibitors has been hampered by the limited number of pathway components that are amenable to small molecule inhibition. Here, we used a chemical genetic screen to identify a small molecule, XAV939, which selectively inhibits beta-catenin-mediated transcription. XAV939 stimulates beta-catenin degradation by stabilizing axin, the concentration-limiting component of the destruction complex. Using a quantitative chemical proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2. Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degradation through the ubiquitin-proteasome pathway. Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Family-wide analysis of poly(ADP-ribose) polymerase activity.

            The poly(adenosine diphosphate (ADP)-ribose) polymerase (PARP) protein family generates ADP-ribose (ADPr) modifications onto target proteins using NAD(+) as substrate. Based on the composition of three NAD(+) coordinating amino acids, the H-Y-E motif, each PARP is predicted to generate either poly(ADPr) (PAR) or mono(ADPr) (MAR). However, the reaction product of each PARP has not been clearly defined, and is an important priority since PAR and MAR function via distinct mechanisms. Here we show that the majority of PARPs generate MAR, not PAR, and demonstrate that the H-Y-E motif is not the sole indicator of PARP activity. We identify automodification sites on seven PARPs, and demonstrate that MAR and PAR generating PARPs modify similar amino acids, suggesting that the sequence and structural constraints limiting PARPs to MAR synthesis do not limit their ability to modify canonical amino-acid targets. In addition, we identify cysteine as a novel amino-acid target for ADP-ribosylation on PARPs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tankyrase, a poly(ADP-ribose) polymerase at human telomeres.

              Tankyrase, a protein with homology to ankyrins and to the catalytic domain of poly(adenosine diphosphate-ribose) polymerase (PARP), was identified and localized to human telomeres. Tankyrase binds to the telomeric protein TRF1 (telomeric repeat binding factor-1), a negative regulator of telomere length maintenance. Like ankyrins, tankyrase contains 24 ankyrin repeats in a domain responsible for its interaction with TRF1. Recombinant tankyrase was found to have PARP activity in vitro, with both TRF1 and tankyrase functioning as acceptors for adenosine diphosphate (ADP)-ribosylation. ADP-ribosylation of TRF1 diminished its ability to bind to telomeric DNA in vitro, suggesting that telomere function in human cells is regulated by poly(ADP-ribosyl)ation.
                Bookmark

                Author and article information

                Contributors
                +442078486478 , mark.pfuhl@kcl.ac.uk
                Journal
                Biomol NMR Assign
                Biomol NMR Assign
                Biomolecular Nmr Assignments
                Springer Netherlands (Dordrecht )
                1874-2718
                1874-270X
                7 March 2019
                7 March 2019
                2019
                : 13
                : 1
                : 255-260
                Affiliations
                [1 ]ISNI 0000 0001 1271 4623, GRID grid.18886.3f, Divisions of Structural Biology & Cancer Biology, , The Institute of Cancer Research (ICR), ; London, SW7 3RP UK
                [2 ]ISNI 0000 0001 1271 4623, GRID grid.18886.3f, Division of Cancer Therapeutics, , The Institute of Cancer Research (ICR), ; London, SW7 3RP UK
                [3 ]ISNI 0000 0001 2322 6764, GRID grid.13097.3c, School of Cardiovascular Medicine and Sciences and Randall Centre, , King’s College London, ; Guy’s Campus, London, SE1 1UL UK
                Author information
                http://orcid.org/0000-0001-9592-6639
                Article
                9887
                10.1007/s12104-019-09887-w
                6439159
                30847846
                436cc20f-995f-45e6-aff7-ecbf76c93cc9
                © The Author(s) 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 8 February 2019
                : 2 March 2019
                Funding
                Funded by: Institute of Cancer Research
                Award ID: Faringdon Proof of Concept Fund Award
                Award Recipient :
                Funded by: Cancer Research UK
                Award ID: C47521/A16217
                Award ID: C309/A11566
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001255, Lister Institute of Preventive Medicine;
                Award ID: n.a.
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100004440, Wellcome Trust;
                Award ID: WT102360/13/Z
                Award Recipient :
                Categories
                Article
                Custom metadata
                © Springer Nature B.V. 2019

                Biophysics
                adp-ribosylation,ubiquitylation,ankyrin repeats,signaling
                Biophysics
                adp-ribosylation, ubiquitylation, ankyrin repeats, signaling

                Comments

                Comment on this article